Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Nanterre, France Clinical Trials

A listing of Nanterre, France clinical trials actively recruiting patients volunteers.

RESULTS

Found (18) clinical trials

Seroprevalence and Immunoprotection Against COVID-19 in Parisian Children

Background of the study: The fraction of undiagnosed cases is a critical epidemiological characteristic that modulates the epidemic potential of SARS-CoV-2 emerging respiratory virus. These subjects most often present themselves in benign or totally asymptomatic form, although they are likely to spread the virus in the general population. The containment …

Phase N/A

6.55 miles

Learn More »

Tendon Vibrations Effect on Upper Limb Motor Recovery After Recent Stroke

Stroke is the leading cause of severe acquired disabilities in adults. It can affect sensory and motor functions which are closely entangled. Among them, upper limb function is often strongly impaired. In this study the investigators are interested in the eventuality to improve motor recovery by the mean of stimulating …

Phase N/A

6.66 miles

Learn More »

Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib

Carcinosarcomas (CS) (malignant mixed Mllerian tumors) are highly aggressive and rare tumors with a worldwide annual incidence between 0.5-3.3 cases/100.000 women. Gynecological CS, i.e. ovarian CS (OCS) and uterine CS (UCS), have a 5-year overall survival (OS) < 10% and a poor prognosis. After initial treatment (surgery +/- adjuvant radiotherapies …

Phase

6.69 miles

Learn More »

Validation of the Diagnostic Performance of the Sleep Apnea Syndrome by the Withings HWA09 Device

Subjects are patients having a prescription for a one-night polysomnographic consultation in order to diagnose potential sleep disorders. The investigator will collect the consent before including any patient in this study. The study last one night per patient, during which saturation signal recordings and the sleep apnea detection will be …

Phase N/A

7.13 miles

Learn More »

Observational Study in Diagnosed Patients COVID-19 Supported on an Outpatient Basis. (COVID-PSL)

Most of the descriptive studies relating to COVID-19 relate to the severe forms of the disease managed in the hospital sector. Few data have been published on moderate forms, requiring no hospitalization, of strict outpatient management. These so-called moderate forms, however, constitute the majority of cases of COVID-19 (approximately 80%). …

Phase N/A

7.81 miles

Learn More »

Acalabrutinib Study With Best Supportive Care Versus Best Supportive Care in Subjects Hospitalized With COVID-19.

CALAVI will investigate the safety, efficacy and pharmacokinetics of acalabrutinib together with Best Supportive Care in the treatment of COVID-19.

Phase

9.09 miles

Learn More »

Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II Study

This multicenter, prospective, open-labeled 2-arm, randomized non-comparative phase II trial. This phase II trial is based on a 2-stage Simon's optimal design. Randomization 1:1 with 1 patient randomized in experimental arm A (association of nivolumab plus relatlimab) and 1 patient randomized in arm B (treatment by nivolumab alone).

Phase

9.5 miles

Learn More »

A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma or Malignant Pheochromocytoma/Paraganglioma

EO2401 is an innovative cancer peptide therapeutic vaccine based on the homologies between Tumor Associated Antigens and microbiome-derived peptides that will be administered in combination with nivolumab to generate preliminary safety and efficacy data in patients with Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma.

Phase

9.51 miles

Learn More »